Search

everythinglearnresearchcommunity

for

Search:↓

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Inhibiting ODC can prevent UV-induced skin cancer.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

New understanding and treatments for hair loss are improving, but more research is needed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.